NL1028193A1 - Farmaceutisch werkzame verbindingen. - Google Patents

Farmaceutisch werkzame verbindingen.

Info

Publication number: NL1028193A1
Authority: NL; Netherlands
Prior art keywords: active compounds; pharmaceutically active; pharmaceutically; compounds; active
Prior art date: 2004-02-04

Application number

NL1028193A

Other languages

English (en)

Other versions

NL1028193C2 (nl

Inventor

Andrew Antony Calabrese

David Sebastien Fradet

David Hepworth

Mark Lansdell

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-02-04

Filing date

2005-02-04

Publication date

2005-08-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34864830&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL1028193(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-06-03 Priority claimed from GB0412417A external-priority patent/GB0412417D0/en

2004-11-19 Priority claimed from GB0425530A external-priority patent/GB0425530D0/en

2005-02-04 Application filed by Pfizer filed Critical Pfizer

2005-08-08 Publication of NL1028193A1 publication Critical patent/NL1028193A1/nl

2006-04-20 Application granted granted Critical

2006-04-20 Publication of NL1028193C2 publication Critical patent/NL1028193C2/nl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Obesity (AREA)
Hematology (AREA)
Psychiatry (AREA)
Immunology (AREA)
Gynecology & Obstetrics (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Pregnancy & Childbirth (AREA)
Anesthesiology (AREA)
Addiction (AREA)
Gastroenterology & Hepatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)

NL1028193A 2004-02-04 2005-02-04 Farmaceutisch werkzame verbindingen. NL1028193C2 (nl)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
GBGB0402492.3A GB0402492D0 (en)	2004-02-04	2004-02-04	Pharmaceutically active compounds
GB0402492		2004-02-04
GB0412417A GB0412417D0 (en)	2004-06-03	2004-06-03	Pharmaceutically active compounds
GB0412417		2004-06-03
GB0425530A GB0425530D0 (en)	2004-11-19	2004-11-19	Pharmaceutically active compounds
GB0425530		2004-11-19

Publications (2)

Publication Number	Publication Date
NL1028193A1 true NL1028193A1 (nl)	2005-08-08
NL1028193C2 NL1028193C2 (nl)	2006-04-20

Family

ID=34864830

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL1028193A NL1028193C2 (nl)	2004-02-04	2005-02-04	Farmaceutisch werkzame verbindingen.

Country Status (25)

Country	Link
EP (1)	EP1716135B1 (nl)
JP (1)	JP4031814B2 (nl)
KR (1)	KR100830763B1 (nl)
CN (1)	CN1930146A (nl)
AP (1)	AP2006003699A0 (nl)
AR (1)	AR048232A1 (nl)
AT (1)	ATE511507T1 (nl)
AU (1)	AU2005213538A1 (nl)
BR (1)	BRPI0507435A (nl)
CA (1)	CA2555800C (nl)
CR (1)	CR8545A (nl)
EA (1)	EA011159B1 (nl)
EC (1)	ECSP066751A (nl)
GB (1)	GB0402492D0 (nl)
GE (1)	GEP20084361B (nl)
IL (1)	IL177004A0 (nl)
MA (1)	MA28348A1 (nl)
NL (1)	NL1028193C2 (nl)
NO (1)	NO20063944L (nl)
PA (1)	PA8623101A1 (nl)
PE (1)	PE20050772A1 (nl)
TW (1)	TWI300066B (nl)
UY (1)	UY28737A1 (nl)
WO (1)	WO2005077935A1 (nl)
ZA (1)	ZA200606236B (nl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2617654A1 (en) *	2005-08-04	2007-02-08	Pfizer Limited	Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
KR20080048502A (ko) *	2005-09-29	2008-06-02	머크 앤드 캄파니 인코포레이티드	멜라노코르틴-4 수용체 조절제로서의 아실화스피로피페리딘 유도체
CA2625877A1 (en) *	2005-10-18	2007-04-26	Merck & Co., Inc.	Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
AU2007219236B2 (en)	2006-02-23	2012-06-21	Pfizer Limited	Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
JP5243274B2 (ja) *	2006-02-23	2013-07-24	ファイザー・リミテッド	４型メラノコルチン受容体アゴニストのピペリジノイルピロリジン
KR20100049644A (ko)	2007-08-07	2010-05-12	다케다 야쿠힌 고교 가부시키가이샤	안드로겐 수용체 조절제로서의 피롤리딘-2-온 유도체
UA99555C2 (en)	2008-11-12	2012-08-27	Элджи Лайф Саенсез Лтд.	Melanocortin receptor agonists
US9044606B2 (en)	2010-01-22	2015-06-02	Ethicon Endo-Surgery, Inc.	Methods and devices for activating brown adipose tissue using electrical energy
US8476227B2 (en)	2010-01-22	2013-07-02	Ethicon Endo-Surgery, Inc.	Methods of activating a melanocortin-4 receptor pathway in obese subjects
US9981960B2 (en)	2014-05-29	2018-05-29	Mitsubishi Tanabe Pharma Corporation	Pyrrolidine compound and application as melanocortin receptor agonist
US10092738B2 (en)	2014-12-29	2018-10-09	Ethicon Llc	Methods and devices for inhibiting nerves when activating brown adipose tissue
US10080884B2 (en)	2014-12-29	2018-09-25	Ethicon Llc	Methods and devices for activating brown adipose tissue using electrical energy
PE20180690A1 (es)	2015-04-27	2018-04-23	Intercept Pharmaceuticals Inc	Composiciones de acido obeticolico y metodos de uso
US10301286B2 (en) *	2015-08-04	2019-05-28	Astellas Pharma Inc.	Piperazine derivative
CN112694436B (zh) *	2020-12-30	2022-07-08	济南周行医药科技有限公司	一种槟榔碱的合成方法
EP4317150A4 (en) *	2021-05-06	2024-10-30	Lg Chem, Ltd.	CRYSTAL FORM VII OF A MELANOCORTIN RECEPTOR AGONIST COMPOUND AND METHOD FOR THE PREPARATION THEREOF
CN114211258B (zh) *	2021-11-04	2023-09-26	江阴市大久金属科技有限公司	高精密无缝钢管制备工艺

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2439152C (en) *	2001-02-28	2008-06-17	Merck & Co., Inc.	Acylated piperidine derivatives as melanocortin-4 receptor agonists
ES2272703T3 (es) *	2001-02-28	2007-05-01	MERCK & CO., INC.	Derivados de piperidina acilados como agonistas de receptor de melanocortina-4.

2004
- 2004-02-04 GB GBGB0402492.3A patent/GB0402492D0/en not_active Ceased
2005
- 2005-01-26 EA EA200601279A patent/EA011159B1/ru not_active IP Right Cessation
- 2005-01-26 CN CNA2005800075736A patent/CN1930146A/zh active Pending
- 2005-01-26 AU AU2005213538A patent/AU2005213538A1/en not_active Abandoned
- 2005-01-26 CA CA2555800A patent/CA2555800C/en not_active Expired - Fee Related
- 2005-01-26 BR BRPI0507435-5A patent/BRPI0507435A/pt not_active IP Right Cessation
- 2005-01-26 AT AT05702363T patent/ATE511507T1/de not_active IP Right Cessation
- 2005-01-26 EP EP05702363A patent/EP1716135B1/en not_active Expired - Lifetime
- 2005-01-26 KR KR1020067015811A patent/KR100830763B1/ko not_active Expired - Fee Related
- 2005-01-26 GE GEAP20059564A patent/GEP20084361B/en unknown
- 2005-01-26 AP AP2006003699A patent/AP2006003699A0/xx unknown
- 2005-01-26 WO PCT/IB2005/000208 patent/WO2005077935A1/en not_active Ceased
- 2005-01-26 JP JP2006551945A patent/JP4031814B2/ja not_active Expired - Fee Related
- 2005-02-02 PE PE2005000122A patent/PE20050772A1/es not_active Application Discontinuation
- 2005-02-03 AR ARP050100409A patent/AR048232A1/es not_active Application Discontinuation
- 2005-02-03 TW TW094103372A patent/TWI300066B/zh active
- 2005-02-03 UY UY28737A patent/UY28737A1/es not_active Application Discontinuation
- 2005-02-04 PA PA20058623101A patent/PA8623101A1/es unknown
- 2005-02-04 NL NL1028193A patent/NL1028193C2/nl not_active IP Right Cessation
2006
- 2006-07-20 IL IL177004A patent/IL177004A0/en unknown
- 2006-07-27 ZA ZA200606236A patent/ZA200606236B/xx unknown
- 2006-08-03 EC EC2006006751A patent/ECSP066751A/es unknown
- 2006-08-03 CR CR8545A patent/CR8545A/es not_active Application Discontinuation
- 2006-08-04 MA MA29242A patent/MA28348A1/fr unknown
- 2006-09-04 NO NO20063944A patent/NO20063944L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
BRPI0507435A (pt)	2007-07-03
CN1930146A (zh)	2007-03-14
PE20050772A1 (es)	2005-10-31
NL1028193C2 (nl)	2006-04-20
AU2005213538A1 (en)	2005-08-25
PA8623101A1 (es)	2006-05-16
ZA200606236B (en)	2008-04-30
ATE511507T1 (de)	2011-06-15
IL177004A0 (en)	2006-12-10
CA2555800C (en)	2010-06-15
WO2005077935A1 (en)	2005-08-25
GB0402492D0 (en)	2004-03-10
MA28348A1 (fr)	2006-12-01
TW200526625A (en)	2005-08-16
TWI300066B (en)	2008-08-21
CR8545A (es)	2007-09-03
EA011159B1 (ru)	2009-02-27
CA2555800A1 (en)	2005-08-25
JP4031814B2 (ja)	2008-01-09
JP2007534668A (ja)	2007-11-29
EA200601279A1 (ru)	2006-12-29
EP1716135B1 (en)	2011-06-01
AP2006003699A0 (en)	2006-08-31
NO20063944L (no)	2006-10-31
EP1716135A1 (en)	2006-11-02
KR100830763B1 (ko)	2008-05-19
AR048232A1 (es)	2006-04-12
UY28737A1 (es)	2005-09-30
GEP20084361B (en)	2008-04-29
ECSP066751A (es)	2006-11-16
KR20060127125A (ko)	2006-12-11

Publication	Publication Date	Title
NL1029015A1 (nl)	2005-11-15	Therapeutische verbindingen.
NL1028967A1 (nl)	2005-11-08	4-Fenylamino-chinazoline-6-yl-amiden.
ATE477257T1 (de)	2010-08-15	Piperidinylamino-thienoä2,3-dü- pyrimidinverbindungen
NO20051522D0 (no)	2005-03-22	Kabelskjotbeskytter.
DE502006007967D1 (de)	2010-11-11	Wirkstoffkombinationen
EP1790612A4 (en)	2011-07-06	NANO CAPSULE STRUCTURE
DK1737831T3 (da)	2013-08-19	Neurologisk aktive forbindelser
NO20053210D0 (no)	2005-06-30	Linneslakkompensator.
NL1028193A1 (nl)	2005-08-08	Farmaceutisch werkzame verbindingen.
NO20041374L (no)	2005-10-03	Bolgekraftverk.
ATE422819T1 (de)	2009-03-15	Fungizide wirkstoffkombination
NL1030382A1 (nl)	2006-05-11	Gesubstitueerde N-sulfonylaminobenzyl-2-fenoxyaceetamide verbindingen.
NO20052746D0 (no)	2005-06-08	Avlopsenhet.
NO20040762L (no)	2005-08-22	Stromskinne.
DE602005018720D1 (de)	2010-02-25	Traktor.
ATE542424T1 (de)	2012-02-15	Fungizide wirkstoffkombination
NO20052482D0 (no)	2005-05-23	Redningskokong.
ES1058102Y (es)	2005-02-16	Lentilla terapeutica.
DE502005001784D1 (de)	2007-12-06	Fungizide wirkstoffkombinationen
DK1720557T3 (da)	2011-02-14	Hurtig-opløselig, smagsmaskeret tablet
NL1028622A1 (nl)	2005-09-27	Stelwig.
NL1025196A1 (nl)	2004-02-24	Hark-Zeef-Vork.
NL1026117A1 (nl)	2005-11-08	Rolstoel.
ES1057528Y (es)	2004-12-01	Estructura soporte.
FR2892698B1 (fr)	2007-12-28	Quille active

Legal Events

Date	Code	Title	Description
2005-10-03	AD1A	A request for search or an international type search has been filed
2006-02-01	RD2N	Patents in respect of which a decision has been taken or a report has been made (novelty report)	Effective date: 20051215
2006-07-03	PD2B	A search report has been drawn up
2010-09-15	V1	Lapsed because of non-payment of the annual fee	Effective date: 20100901